Our TRI CEO, Eric Zudak, shares his experience at EADV 2026 (including a mention of his extensive and expanding collection of travel chargers.) See the whole story HERE. One takeaway from EADV was the continued and overwhelmingly enthusiastic response to LAMA: Thalocan’s patented Lesion Area Mapping Assistant, our cloud-based solution for enhancing lesion assessment in…
Heading to EADV! In two weeks, our Thalocan Research Innovations CEO Eric Zudak will be attending the 2026 EADV Congress in Vienna. The congress showcases the latest science, research, and best practices across all areas of dermato-venereology, offering hands-on workshops, sub-specialty sessions, and industry presentations that cover the full spectrum of dermatology and venereology topics.…
Today is World Vitiligo Day, a global campaign dedicated to raising awareness, ending social stigma, and advocating for people living with vitiligo. Originally launched in 2011, the day unites the international community to promote research and support for those affected. At Thalocan Research Innovations Research Innovtions, we applaud the work of the GLOBAL VITILIGO FOUNDATION…
Thalocan Research Innovations Lesion Area Mapping Assistant (LAMA) was a HIT at the American Academy of Dermatology 2026 Annual meeting in Denver this past weekend. Many thanks to our COO, Cyrus Mirakhor for running such seamless and informative demonstrations. The Lesion Area Mapping Assistant is Thalocan’s cloud-based solution for enhancing lesion assessment in dermatologic clinical…
